The End of GLP-1 Compounding

Federally-registered compounding facilities stopped making tirzepatide on May 22. This transition is significant for patients, and we at PSM think there are four things you should be watching for.

[...]

Pharmaceutical Border Security

Pharmaceutical border security Every day, inspectors from Customs and Border Protection, the Food and Drug Administration, and the Drug Enforcement Administration intercept scary medical products  entering the U.S. This work is incredibly important to protect the safety of American patients and it’s difficult because criminals never stop innovating. PSM supports the work of border inspectors…

[...]